Veterinary Medicines

Mamyzin-A pomata intramammaria per bovine in asciutta

Authorised
  • Benethamine penicillin
  • Penethamate hydriodide
  • Framycetin sulfate
Download as PDF

Product identification

Medicine name:
Mamyzin-A pomata intramammaria per bovine in asciutta
Active substance:
  • Benethamine penicillin
  • Penethamate hydriodide
  • Framycetin sulfate
Target species:
  • Cattle (cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Benethamine penicillin
    100.00
    milligram(s)
    /
    5.00
    millilitre(s)
  • Penethamate hydriodide
    280.00
    milligram(s)
    /
    5.00
    millilitre(s)
  • Framycetin sulfate
    100.00
    milligram(s)
    /
    5.00
    millilitre(s)
Pharmaceutical form:
  • Intramammary gel
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (cow)
      • Meat and offal
        10
        day
      • Milk
        36
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RC22
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Italy
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lohmann Pharma Herstellung GmbH
  • Haupt Pharma Latina S.r.l.
Responsible authority:
  • Ministry Of Health
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Italian (PDF)
Published on: 2/03/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."